{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T01:04:56Z","timestamp":1783386296635,"version":"3.54.6"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T00:00:00Z","timestamp":1643414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T00:00:00Z","timestamp":1643414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Few published data describe how joint involvement, the most prevalent extraintestinal manifestation, affects quality of life (QoL) of children with Crohn\u2019s disease (CD). Arthritis and arthralgia rates in pediatric CD patients are reportedly 3\u201324% and 17\u201322%, respectively, but studies on pre-emptive and systematic screening of joint involvement with detailed musculoskeletal rheumatological exam are lacking. More detailed data collection on joint involvement improves our understanding of how arthropathy relates to disease activity and QoL measured by the Pediatric CD Activity Index (PCDAI) and IMPACT-III questionnaire. Our study aims were to assess joint involvement in pediatric CD and correlate it with the PCDAI and IMPACT-III.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this cross-sectional, observational study, a pediatric gastroenterologist assessed consecutively-seen pediatric CD patients at a tertiary care center. Patients were screened for prevalence of current and previous arthropathy, including arthritis, enthesitis and arthralgia. A single experienced pediatric rheumatologist evaluated detailed musculoskeletal history, joint status, and modified Juvenile Arthritis Multidimensional Assessment Reports (JAMAR). PCDAI, IMPACT-III, sacroiliac MRI, and HLA-B27 genetic testing were also completed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 82 (male:female, 1.2:1; age, 13.7\u2009\u00b1\u20093.2\u2009years) patients were involved in this study. Mean disease duration at time of study was 21.6\u2009\u00b1\u200921\u2009months; eight of the patients were newly-diagnosed. Of the 82 patients, 29 (35%) had evidence of arthritis; for 24 of those, this was revealed by physical exam during cross-sectional screening, and by prior documentation for the remaining five patients. Joint examination confirmed active arthritis in 8\/24 (33%), active enthesitis in 1\/24 (4%), and evidence of previous arthritis in 15\/24 (62.5%) patients. Hip (41%) and knee (38%) joints were most commonly affected. Cumulative incidence of arthralgia was 48% (39\/82), and 46% (18\/39) of those patients had only arthralgia without arthritis, usually affecting the knee. Axial involvement was present in 10\/82 (12%) patients. Joint involvement correlated with more severe CD disease activity, specifically higher PCDAI and lower IMPACT-III scores, and increased requirement for infliximab treatment. Sacroiliitis and HLA-B27 positivity were insignificant factors in this cohort.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>When a rheumatologist performed the assessment, joint involvement in pediatric CD was more prevalent than previously reported, in this cross-sectional study. Arthritis was associated with more severe CD disease activity and lower QoL.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12969-022-00664-z","type":"journal-article","created":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T18:02:37Z","timestamp":1643479357000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Joint involvement, disease activity and quality of life in pediatric Crohn\u2019s disease \u2013 a cross-sectional study"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7272-7119","authenticated-orcid":false,"given":"Beata","family":"Derfalvi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kriszta Katinka","family":"Boros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doloresz","family":"Szabo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabor","family":"Bozsaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aron","family":"Cseh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabor","family":"Rudas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katalin Eszter","family":"Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabor","family":"Veres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,29]]},"reference":[{"issue":"2","key":"664_CR1","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1097\/MPG.0b013e318093f4b0","volume":"46","author":"FA Jose","year":"2008","unstructured":"Jose FA, Heyman MB. Extraintestinal manifestations of inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2008;46(2):124\u201333. https:\/\/doi.org\/10.1097\/MPG.0b013e318093f4b0.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"3","key":"664_CR2","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1053\/j.gastro.2005.12.019","volume":"130","author":"L Beaugerie","year":"2006","unstructured":"Beaugerie L, Seksik P, Nion-Larmurier I, Gendre JP, Cosnes J. Predictors of Crohn\u2019s disease. Gastroenterology. 2006;130(3):650\u20136. https:\/\/doi.org\/10.1053\/j.gastro.2005.12.019.","journal-title":"Gastroenterology."},{"issue":"6","key":"664_CR3","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1053\/j.gastro.2011.01.055","volume":"140","author":"J Cosnes","year":"2011","unstructured":"Cosnes J, Gower-Rousseau C, Seksik P, Cortot A. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology. 2011;140(6):1785\u201394. https:\/\/doi.org\/10.1053\/j.gastro.2011.01.055.","journal-title":"Gastroenterology."},{"issue":"11","key":"664_CR4","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1002\/ibd.22898","volume":"18","author":"G Savoye","year":"2012","unstructured":"Savoye G, Salleron J, Gower-Rousseau C, Dupas JL, Vernier-Massouille G, Fumery M, et al. Clinical predictors at diagnosis of disabling pediatric Crohn\u2019s disease. Inflamm Bowel Dis. 2012;18(11):2072\u20138. https:\/\/doi.org\/10.1002\/ibd.22898.","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"664_CR5","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1097\/MPG.0b013e31829f7d8c","volume":"57","author":"KE Muller","year":"2013","unstructured":"Muller KE, Lakatos PL, Arato A, Kovacs JB, Varkonyi A, Szucs D, et al. Incidence, Paris classification, and follow-up in a nationwide incident cohort of pediatric patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2013;57(5):576\u201382. https:\/\/doi.org\/10.1097\/MPG.0b013e31829f7d8c.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"2","key":"664_CR6","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1097\/MPG.0b013e3181ca4db4","volume":"51","author":"JL Dotson","year":"2010","unstructured":"Dotson JL, Hyams JS, Markowitz J, LeLeiko NS, Mack DR, Evans JS, et al. Extraintestinal manifestations of pediatric inflammatory bowel disease and their relation to disease type and severity. J Pediatr Gastroenterol Nutr. 2010;51(2):140\u20135. https:\/\/doi.org\/10.1097\/MPG.0b013e3181ca4db4.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"1","key":"664_CR7","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/ibd.20604","volume":"15","author":"FA Jose","year":"2009","unstructured":"Jose FA, Garnett EA, Vittinghoff E, Ferry GD, Winter HS, Baldassano RN, et al. Development of extraintestinal manifestations in pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis. 2009;15(1):63\u20138. https:\/\/doi.org\/10.1002\/ibd.20604.","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"664_CR8","doi-asserted-by":"publisher","first-page":"236","DOI":"10.5223\/pghn.2016.19.4.236","volume":"19","author":"YA Lee","year":"2016","unstructured":"Lee YA, Chun P, Hwang EH, Mun SW, Lee YJ, Park JH. Clinical features and extraintestinal manifestations of Crohn disease in children. Pediatr Gastroenterol Hepatol Nutr. 2016;19(4):236\u201342. https:\/\/doi.org\/10.5223\/pghn.2016.19.4.236.","journal-title":"Pediatr Gastroenterol Hepatol Nutr"},{"issue":"11","key":"664_CR9","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.3899\/jrheum.170168","volume":"44","author":"O Nir","year":"2017","unstructured":"Nir O, Rinawi F, Amarilyo G, Harel L, Shamir R, Assa A. Phenotypic features and longterm outcomes of pediatric inflammatory bowel disease patients with arthritis and arthralgia. J Rheumatol. 2017;44(11):1636\u201343. https:\/\/doi.org\/10.3899\/jrheum.170168.","journal-title":"J Rheumatol"},{"issue":"5","key":"664_CR10","doi-asserted-by":"publisher","first-page":"3363","DOI":"10.3892\/etm.2016.3756","volume":"12","author":"Y Zhou","year":"2016","unstructured":"Zhou Y, Huang Y. Inflammatory bowel disease in Chinese children: a retrospective analysis of 49 cases. Exp Ther Med. 2016;12(5):3363\u20138. https:\/\/doi.org\/10.3892\/etm.2016.3756.","journal-title":"Exp Ther Med"},{"issue":"11","key":"664_CR11","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1093\/ibd\/izy137","volume":"24","author":"N Ouldali","year":"2018","unstructured":"Ouldali N, Hugot JP, Viala J, Damir M, Martinez-Vinson C, Meinzer U. Early arthritis is associated with failure of immunosuppressive drugs and severe pediatric Crohn\u2019s disease evolution. Inflamm Bowel Dis. 2018;24(11):2423\u201330. https:\/\/doi.org\/10.1093\/ibd\/izy137.","journal-title":"Inflamm Bowel Dis"},{"key":"664_CR12","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jpeds.2018.12.005","volume":"209","author":"R Levy","year":"2019","unstructured":"Levy R, Amarilyo G, Tal R, Amir J, Assa A, Rinawi F, et al. Musculoskeletal manifestations as presenting symptoms of inflammatory bowel disease in children and adolescents. J Pediatr. 2019;209:233\u20135. https:\/\/doi.org\/10.1016\/j.jpeds.2018.12.005.","journal-title":"J Pediatr"},{"issue":"1","key":"664_CR13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1136\/ard.2010.133645","volume":"70","author":"M Rudwaleit","year":"2011","unstructured":"Rudwaleit M, van der Heijde D, Landew\u00e9 R, Akkoc N, Brandt J, Chou CT, et al. The assessment of SpondyloArthritis international society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis. 2011;70(1):25\u201331. https:\/\/doi.org\/10.1136\/ard.2010.133645.","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"664_CR14","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s11926-016-0603-y","volume":"18","author":"A Adrovic","year":"2016","unstructured":"Adrovic A, Barut K, Sahin S, Kasapcopur O. Juvenile spondyloarthropathies. Curr Rheumatol Rep. 2016;18(8):55. https:\/\/doi.org\/10.1007\/s11926-016-0603-y.","journal-title":"Curr Rheumatol Rep"},{"issue":"11","key":"664_CR15","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1007\/s10067-015-3029-4","volume":"34","author":"A Aggarwal","year":"2015","unstructured":"Aggarwal A, Misra DP. Enthesitis-related arthritis. Clin Rheumatol. 2015;34(11):1839\u201346. https:\/\/doi.org\/10.1007\/s10067-015-3029-4.","journal-title":"Clin Rheumatol"},{"key":"664_CR16","doi-asserted-by":"publisher","first-page":"601518","DOI":"10.3389\/fimmu.2021.601518","volume":"12","author":"CG Kavadichanda","year":"2021","unstructured":"Kavadichanda CG, Geng J, Bulusu SN, Negi VS, Raghavan M. Spondyloarthritis and the human leukocyte antigen (HLA)-B(*)27 connection. Front Immunol. 2021;12:601518. https:\/\/doi.org\/10.3389\/fimmu.2021.601518.","journal-title":"Front Immunol"},{"key":"664_CR17","doi-asserted-by":"publisher","first-page":"108415","DOI":"10.1016\/j.clim.2020.108415","volume":"215","author":"A Ricciuto","year":"2020","unstructured":"Ricciuto A, Sherman PM, Laxer RM. Gut microbiota in chronic inflammatory disorders: a focus on pediatric inflammatory bowel diseases and juvenile idiopathic arthritis. Clin Immunol. 2020;215:108415. https:\/\/doi.org\/10.1016\/j.clim.2020.108415.","journal-title":"Clin Immunol"},{"issue":"Suppl4","key":"664_CR18","doi-asserted-by":"publisher","first-page":"iv67","DOI":"10.1093\/rheumatology\/keaa408","volume":"59","author":"K Sharif","year":"2020","unstructured":"Sharif K, Bridgewood C, Dubash S, McGonagle D. Intestinal and enthesis innate immunity in early axial spondyloarthropathy. Rheumatology (Oxford). 2020;59(Suppl4):iv67\u201378.","journal-title":"Rheumatology (Oxford)"},{"issue":"17","key":"664_CR19","doi-asserted-by":"publisher","first-page":"6401","DOI":"10.3390\/ijms21176401","volume":"21","author":"H Tsukazaki","year":"2020","unstructured":"Tsukazaki H, Kaito T. The role of the IL-23\/IL-17 pathway in the pathogenesis of spondyloarthritis. Int J Mol Sci. 2020;21(17):6401.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"664_CR20","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/ecco-jcc\/jju025","volume":"9","author":"M van der Have","year":"2015","unstructured":"van der Have M, Brakenhoff LK, van Erp SJ, Kaptein AA, Leenders M, Scharloo M, et al. Back\/joint pain, illness perceptions and coping are important predictors of quality of life and work productivity in patients with inflammatory bowel disease: a 12-month longitudinal study. J Crohns Colitis. 2015;9(3):276\u201383. https:\/\/doi.org\/10.1093\/ecco-jcc\/jju025.","journal-title":"J Crohns Colitis."},{"issue":"6","key":"664_CR21","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1097\/MPG.0000000000000239","volume":"58","author":"A Levine","year":"2014","unstructured":"Levine A, Koletzko S, Turner D, Escher JC, Cucchiara S, de Ridder L, et al. ESPGHAN revised Porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents. J Pediatr Gastroenterol Nutr. 2014;58(6):795\u2013806. https:\/\/doi.org\/10.1097\/MPG.0000000000000239.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"6","key":"664_CR22","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1136\/ard.2007.084244","volume":"68","author":"WP Maksymowych","year":"2009","unstructured":"Maksymowych WP, Mallon C, Morrow S, Shojania K, Olszynski WP, Wong RL, et al. Development and validation of the Spondyloarthritis research consortium of Canada (SPARCC) Enthesitis index. Ann Rheum Dis. 2009;68(6):948\u201353. https:\/\/doi.org\/10.1136\/ard.2007.084244.","journal-title":"Ann Rheum Dis"},{"key":"664_CR23","unstructured":"Villa-Forte A. Evaluation of the patient with joint symptoms. In Merck Manual Professional Version Merck & Co, Inc. 2020. Retrieved October 1, 2021, from\u00a0https:\/\/www.merckmanualscom\/en-ca\/professional\/musculoskeletal-and-connective-tissue-disorders\/approach-to-the-patient-with-joint-symptoms\/evaluation-of-the-patient-with-joint-symptoms."},{"issue":"Suppl 11","key":"664_CR24","doi-asserted-by":"publisher","first-page":"S64","DOI":"10.1002\/acr.20577","volume":"63","author":"PJ Mease","year":"2011","unstructured":"Mease PJ. Measures of psoriatic arthritis: Tender and Swollen Joint Assessment, Psoriasis Area and Severity Index (PASI), Nail Psoriasis Severity Index (NAPSI), Modified Nail Psoriasis Severity Index (mNAPSI), Mander\/Newcastle Enthesitis Index (MEI), Leeds Enthesitis Index (LEI), Spondyloarthritis Research Consortium of Canada (SPARCC), Maastricht Ankylosing Spondylitis Enthesis Score (MASES), Leeds Dactylitis Index (LDI), Patient Global for Psoriatic Arthritis, Dermatology Life Quality Index (DLQI), Psoriatic Arthritis Quality of Life (PsAQOL), Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F), Psoriatic Arthritis Response Criteria (PsARC), Psoriatic Arthritis Joint Activity Index (PsAJAI), Disease Activity in Psoriatic Arthritis (DAPSA), and Composite Psoriatic Disease Activity Index (CPDAI). Arthritis Care Res (Hoboken). 2011;63(Suppl 11):S64\u201385.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"10","key":"664_CR25","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1136\/ard.2009.110767","volume":"68","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit M, Jurik AG, Hermann KG, Landewe R, van der Heijde D, Baraliakos X, et al. Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS\/OMERACT MRI group. Ann Rheum Dis. 2009;68(10):1520\u20137. https:\/\/doi.org\/10.1136\/ard.2009.110767.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"664_CR26","doi-asserted-by":"publisher","first-page":"938","DOI":"10.3899\/jrheum.100930","volume":"38","author":"G Filocamo","year":"2011","unstructured":"Filocamo G, Consolaro A, Schiappapietra B, Dalpra S, Lattanzi B, Magni-Manzoni S, et al. A new approach to clinical care of juvenile idiopathic arthritis: the juvenile arthritis multidimensional assessment report. J Rheumatol. 2011;38(5):938\u201353. https:\/\/doi.org\/10.3899\/jrheum.100930.","journal-title":"J Rheumatol"},{"issue":"Suppl 1","key":"664_CR27","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00296-018-3955-y","volume":"38","author":"I Orban","year":"2018","unstructured":"Orban I, Constantin T, Derfalvi B, Sevcic K, Garan D, Kaposzta R, et al. The Hungarian version of the juvenile arthritis multidimensional assessment report (JAMAR). Rheumatol Int. 2018;38(Suppl 1):243\u201350. https:\/\/doi.org\/10.1007\/s00296-018-3955-y.","journal-title":"Rheumatol Int"},{"issue":"3","key":"664_CR28","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1097\/MPG.0b013e3182165d10","volume":"53","author":"CA Ogden","year":"2011","unstructured":"Ogden CA, Akobeng AK, Abbott J, Aggett P, Sood MR, Thomas AG. Validation of an instrument to measure quality of life in British children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2011;53(3):280\u20136. https:\/\/doi.org\/10.1097\/MPG.0b013e3182165d10.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"4","key":"664_CR29","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1097\/00005176-199105000-00005","volume":"12","author":"JS Hyams","year":"1991","unstructured":"Hyams JS, Ferry GD, Mandel FS, Gryboski JD, Kibort PM, Kirschner BS, et al. Development and validation of a pediatric Crohn\u2019s disease activity index. J Pediatr Gastroenterol Nutr. 1991;12(4):439\u201347. https:\/\/doi.org\/10.1097\/00005176-199105000-00005.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"4","key":"664_CR30","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1097\/01.mpg.0000183350.46795.42","volume":"41","author":"J Hyams","year":"2005","unstructured":"Hyams J, Markowitz J, Otley A, Rosh J, Mack D, Bousvaros A, et al. Evaluation of the pediatric Crohn disease activity index: a prospective multicenter experience. J Pediatr Gastroenterol Nutr. 2005;41(4):416\u201321. https:\/\/doi.org\/10.1097\/01.mpg.0000183350.46795.42.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"6","key":"664_CR31","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.3748\/wjg.v23.i6.1067","volume":"23","author":"G Chouliaras","year":"2017","unstructured":"Chouliaras G, Margoni D, Dimakou K, Fessatou S, Panayiotou I, Roma-Giannikou E. Disease impact on the quality of life of children with inflammatory bowel disease. World J Gastroenterol. 2017;23(6):1067\u201375. https:\/\/doi.org\/10.3748\/wjg.v23.i6.1067.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"664_CR32","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3748\/wjg.v20.i1.45","volume":"20","author":"S Cardile","year":"2014","unstructured":"Cardile S, Romano C. Current issues in pediatric inflammatory bowel disease-associated arthropathies. World J Gastroenterol. 2014;20(1):45\u201352. https:\/\/doi.org\/10.3748\/wjg.v20.i1.45.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"664_CR33","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1097\/MPG.0000000000001455","volume":"65","author":"T Greuter","year":"2017","unstructured":"Greuter T, Bertoldo F, Rechner R, Straumann A, Biedermann L, Zeitz J, et al. Extraintestinal manifestations of pediatric inflammatory bowel disease: prevalence, presentation, and anti-TNF treatment. J Pediatr Gastroenterol Nutr. 2017;65(2):200\u20136. https:\/\/doi.org\/10.1097\/MPG.0000000000001455.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"3","key":"664_CR34","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1136\/gut.42.3.387","volume":"42","author":"TR Orchard","year":"1998","unstructured":"Orchard TR, Wordsworth BP, Jewell DP. Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history. Gut. 1998;42(3):387\u201391. https:\/\/doi.org\/10.1136\/gut.42.3.387.","journal-title":"Gut."},{"issue":"8","key":"664_CR35","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1097\/MIB.0000000000000429","volume":"21","author":"SR Vavricka","year":"2015","unstructured":"Vavricka SR, Rogler G, Gantenbein C, Spoerri M, Prinz Vavricka M, Navarini AA, et al. Chronological order of appearance of extraintestinal manifestations relative to the time of IBD diagnosis in the Swiss inflammatory bowel disease cohort. Inflamm Bowel Dis. 2015;21(8):1794\u2013800. https:\/\/doi.org\/10.1097\/MIB.0000000000000429.","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"664_CR36","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/s41430-019-0490-1","volume":"74","author":"S Cohen","year":"2020","unstructured":"Cohen S, Padlipsky J, Yerushalmy-Feler A. Risk factors associated with extraintestinal manifestations in children with inflammatory bowel disease. Eur J Clin Nutr. 2020;74(5):691\u20137. https:\/\/doi.org\/10.1038\/s41430-019-0490-1.","journal-title":"Eur J Clin Nutr"},{"issue":"10","key":"664_CR37","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.dld.2005.04.028","volume":"37","author":"F Conti","year":"2005","unstructured":"Conti F, Borrelli O, Anania C, Marocchi E, Romeo EF, Paganelli M, et al. Chronic intestinal inflammation and seronegative spondyloarthropathy in children. Dig Liver Dis. 2005;37(10):761\u20137. https:\/\/doi.org\/10.1016\/j.dld.2005.04.028.","journal-title":"Dig Liver Dis"},{"key":"664_CR38","doi-asserted-by":"publisher","first-page":"1759720x2199697","DOI":"10.1177\/1759720X21996973","volume":"13","author":"J Evans","year":"2021","unstructured":"Evans J, Sapsford M, McDonald S, Poole K, Raine T, Jadon DR. Prevalence of axial spondyloarthritis in patients with inflammatory bowel disease using cross-sectional imaging: a systematic literature review. Ther Adv Musculoskelet Dis. 2021;13:1759720x21996973.","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"1","key":"664_CR39","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12969-020-00433-w","volume":"18","author":"T Giani","year":"2020","unstructured":"Giani T, Bernardini A, Basile M, Di Maurizo M, Perrone A, Renzo S, et al. Usefulness of magnetic resonance enterography in detecting signs of sacroiliitis in young patients with inflammatory bowel disease. Pediatr Rheumatol Online J. 2020;18(1):42. https:\/\/doi.org\/10.1186\/s12969-020-00433-w.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"9","key":"664_CR40","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1111\/apt.12680","volume":"39","author":"S Leclerc-Jacob","year":"2014","unstructured":"Leclerc-Jacob S, Lux G, Rat AC, Laurent V, Blum A, Chary-Valckenaere I, et al. The prevalence of inflammatory sacroiliitis assessed on magnetic resonance imaging of inflammatory bowel disease: a retrospective study performed on 186 patients. Aliment Pharmacol Ther. 2014;39(9):957\u201362. https:\/\/doi.org\/10.1111\/apt.12680.","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"664_CR41","first-page":"2860","volume":"27","author":"K de Vlam","year":"2000","unstructured":"de Vlam K, Mielants H, Cuvelier C, De Keyser F, Veys EM, De Vos M. Spondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA association. J Rheumatol. 2000;27(12):2860\u20135.","journal-title":"J Rheumatol"},{"key":"664_CR42","doi-asserted-by":"crossref","unstructured":"Horton DB, Sherry DD, Baldassano RN, Weiss PF. Enthesitis is an extraintestinal manifestation of pediatric inflammatory bowel disease. Ann Paediatr Rheumatol. 2012;1(4).","DOI":"10.5455\/apr.102920121510"},{"issue":"3","key":"664_CR43","first-page":"511","volume":"29","author":"O Palm","year":"2002","unstructured":"Palm O, Moum B, Ongre A, Gran JT. Prevalence of ankylosing spondylitis and other spondyloarthropathies among patients with inflammatory bowel disease: a population study (the IBSEN study). J Rheumatol. 2002;29(3):511\u20135.","journal-title":"J Rheumatol"},{"issue":"12","key":"664_CR44","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1080\/003655201317097173","volume":"36","author":"C Salvarani","year":"2001","unstructured":"Salvarani C, Vlachonikolis IG, van der Heijde DM, Fornaciari G, Macchioni P, Beltrami M, et al. Musculoskeletal manifestations in a population-based cohort of inflammatory bowel disease patients. Scand J Gastroenterol. 2001;36(12):1307\u201313. https:\/\/doi.org\/10.1080\/003655201317097173.","journal-title":"Scand J Gastroenterol"},{"issue":"9","key":"664_CR45","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1093\/ecco-jcc\/jjy068","volume":"12","author":"F Charbit-Henrion","year":"2018","unstructured":"Charbit-Henrion F, Parlato M, Hanein S, Duclaux-Loras R, Nowak J, Begue B, et al. Diagnostic yield of next-generation sequencing in very early-onset inflammatory bowel diseases: a multicentre study. J Crohns Colitis. 2018;12(9):1104\u201312. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjy068.","journal-title":"J Crohns Colitis"},{"issue":"6","key":"664_CR46","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1002\/ibd.21493","volume":"17","author":"A Levine","year":"2011","unstructured":"Levine A, Griffiths A, Markowitz J, Wilson DC, Turner D, Russell RK, et al. Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification. Inflamm Bowel Dis. 2011;17(6):1314\u201321. https:\/\/doi.org\/10.1002\/ibd.21493.","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"664_CR47","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1177\/1093526619834807","volume":"22","author":"MA Conrad","year":"2019","unstructured":"Conrad MA, Kelsen JR. Genomic and immunologic drivers of very early-onset inflammatory bowel disease. Pediatr Dev Pathol. 2019;22(3):183\u201393. https:\/\/doi.org\/10.1177\/1093526619834807.","journal-title":"Pediatr Dev Pathol"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-022-00664-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12969-022-00664-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-022-00664-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T18:03:55Z","timestamp":1643479435000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-022-00664-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,29]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["664"],"URL":"https:\/\/doi.org\/10.1186\/s12969-022-00664-z","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,29]]},"assertion":[{"value":"15 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Study approval was obtained from the Hungarian Medical Research Council Scientific and Research Ethics Committee (ETT-TUKEB) Case no.:10434\/2012\/EKU (175\/P1\/12.) Parents\/legal guardians and patients older than 7\u2009years of age signed the informed consent form before any study-related procedures occurred.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent has been given by the patients and parents, via the written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6"}}